Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Tasmin Ara Sultana (she/her/hers)
US Food and Drug Administration
Poster(s):
(T1530-08-54) Critical Formulation Attributes of Naloxone Nasal Spray Products Affecting Nasal Permeation
Tuesday, October 24, 2023
3:30 PM – 4:30 PM
ET